Clinical Trials at Cedars-Sinai Cancer - Tarzana
As of September 2026, 13 paid clinical trials are recruiting at Cedars-Sinai Cancer - Tarzana, located at Cedars-Sinai Multispecialty - Tarzana, 18133 Ventura Blvd Suite 300, Tarzana, CA 91356, phone (818) 981-3818 in Tarzana, California. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 and Early Stage Triple-Negative Breast Carcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at Cedars-Sinai Cancer - Tarzana
·Clear filters·Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Common conditions studied in Tarzana
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (3 active studies)
- Early Stage Triple-Negative Breast Carcinoma (3 active studies)
- Heart Failure (3 active studies)
- Obesity (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Tarzana
- AstraZeneca
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Sanofi
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Tarzana?
There are approximately 42 recruiting clinical trials in Tarzana, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tarzana pay participants?
Most recruiting trials in Tarzana compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tarzana?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tarzana?
The most common conditions under active study in Tarzana include Anatomic Stage II Breast Cancer AJCC v8 (5), Anatomic Stage IIIA Breast Cancer AJCC v8 (3), Early Stage Triple-Negative Breast Carcinoma (3), Heart Failure (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tarzana?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tarzana on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tarzana?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tarzana?
Recruiting research sites in Tarzana include Cedars-Sinai Cancer - Tarzana, Valiance Clinical Research, Valiance Clinical Research - Tarzana, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tarzana right now?
The largest active categories in Tarzana are Cancer & tumors (16), Cardiovascular (6), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Cedars-Sinai Cancer - Tarzana?
Cedars-Sinai Cancer - Tarzana is located at Cedars-Sinai Multispecialty - Tarzana, 18133 Ventura Blvd Suite 300, Tarzana, CA 91356. Use the Google Maps link in the intro above to get directions.
How do I contact Cedars-Sinai Cancer - Tarzana?
You can reach Cedars-Sinai Cancer - Tarzana by phone at (818) 981-3818. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.